Exafib (Rivaroxaban) Tablet

Description

Description

This page contains brief details about the drug rivaroxaban, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.

Date of Approval

Rivaroxaban is an anticoagulant medication that was approved for medical use on 1st July 2011.

Mechanism of Action of Rivaroxaban

Rivaroxaban Tablet is an anticoagulant medication belonging to the class of selective direct Factor Xa inhibitors. Rivaroxaban binds and forms a complex with Factor Xa.  Factor Xa is a natural substance in the body that is responsible for the formation of blood clots. Rivaroxaban is prescribed alone or in combination with low-dose aspirin.

Uses of Rivaroxaban

Rivaroxaban Tablet has been developed to treat venous thromboembolism and its symptoms in adults and pediatric patients older than one month of age. It also prevents the occurrence of stroke, and blood clots in patients with acute critical illness, hospitalized patients, and in people with severe movement restriction. Rivaroxaban reduces the risk of a heart attack in patients diagnosed with coronary artery disease and atrial fibrillation.

Rivaroxaban Dosage available

Rivaroxaban is available as film-coated tablets in doses of 2.5mg, 10mg, 15mg, and 20mg. The accurate dose and frequency vary according to age and medical condition.